Equities analysts forecast that ICU Medical, Incorporated (NASDAQ:ICUI) will report $329.30 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for ICU Medical’s earnings, with estimates ranging from $329.00 million to $329.60 million. ICU Medical posted sales of $95.68 million during the same quarter last year, which suggests a positive year over year growth rate of 244.2%. The firm is expected to announce its next quarterly earnings results after the market closes on Thursday, March 1st.
On average, analysts expect that ICU Medical will report full year sales of $329.30 million for the current year, with estimates ranging from $1.24 billion to $1.25 billion. For the next financial year, analysts forecast that the firm will post sales of $1.34 billion per share. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow ICU Medical.
Separately, Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $232.00 price objective on the stock in a report on Thursday, November 16th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $266.00.
In other news, Director Robert S. Swinney sold 1,000 shares of the business’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $215.10, for a total transaction of $215,100.00. Following the transaction, the director now owns 13,330 shares in the company, valued at approximately $2,867,283. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 724 shares of the business’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $235.00, for a total transaction of $170,140.00. Following the transaction, the director now owns 14,830 shares in the company, valued at approximately $3,485,050. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 25,348 shares of company stock worth $5,582,520. Insiders own 13.60% of the company’s stock.
Several large investors have recently bought and sold shares of the company. Ameritas Investment Partners Inc. increased its holdings in shares of ICU Medical by 4.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock worth $228,000 after purchasing an additional 51 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of ICU Medical by 1.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,468 shares of the medical instruments supplier’s stock worth $1,979,000 after purchasing an additional 146 shares during the period. Suntrust Banks Inc. increased its holdings in shares of ICU Medical by 1.7% during the 4th quarter. Suntrust Banks Inc. now owns 14,617 shares of the medical instruments supplier’s stock worth $3,157,000 after purchasing an additional 239 shares during the period. Public Employees Retirement Association of Colorado increased its holdings in shares of ICU Medical by 0.3% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 100,334 shares of the medical instruments supplier’s stock worth $21,672,000 after purchasing an additional 254 shares during the period. Finally, Profund Advisors LLC increased its stake in ICU Medical by 18.1% in the fourth quarter. Profund Advisors LLC now owns 1,804 shares of the medical instruments supplier’s stock valued at $390,000 after acquiring an additional 276 shares during the period. Institutional investors own 75.52% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2018/02/21/icu-medical-incorporated-icui-expected-to-announce-quarterly-sales-of-329-30-million.html.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.